Issue Information
GastroHep
by
1y ago
GastroHep, Volume 3, Issue 7, Page 417-419, December 2021 ..read more
Visit website
Issue Information
GastroHep
by
1y ago
GastroHep, Volume 3, Issue 6, Page 335-337, November 2021 ..read more
Visit website
Lenvatinib for unresectable hepatocellular carcinoma: the first Indian experience
GastroHep
by Anand V. Kulkarni, Syeda Fatima, Mithun Sharma, Pramod Kumar, Rajesh Gupta, Nagaraja R. Padaki, Nageshwar Reddy
1y ago
GastroHep, Volume 3, Issue 6, Page 407-408, November 2021 ..read more
Visit website
GastroHep Asian Special Edition
GastroHep
by Her Hsin Tsai
1y ago
GastroHep, Volume 3, Issue 6, Page 338-338, November 2021 ..read more
Visit website
Mortality pattern in cirrhosis: A reflection of liver disease burden in India
GastroHep
by Debashis Misra, Kausik Das, Saswata Chatterjee, Parthasarathi Mukherjee, Abhijit Chowdhury
1y ago
ABSTRACT Introduction & Objective Mortality data from high income group countries are frequently used in developing countries for healthcare planning. This study was planned to explore the mortality pattern of cirrhosis in India in terms of survival after diagnosis of cirrhosis, predictors of death and etiology specific effect on mortality. Methods This observational study enrolled newly diagnosed patients with liver disease (n=3193) attending a tertiary care hospital in Kolkata, India between April 2010 and October 2012 and were followed up to September, 2015. Results Patients with cirrho ..read more
Visit website
The Helicobacter pylori detection rate by using combination of rapid urease test at antrum and body versus histopathology in population who stop proton pump inhibitor less than 2 weeks
GastroHep
by Pitchayut Boonyabaramee, Rapat Pittayanon, Anapat Sunpavat, Nathawadee Lerttanatum, Natee Faknak, Naruemon Wisedopas
1y ago
Abstract Background Helicobacter pylori (H.pylori) assessment in patients who stop taking proton pump inhibitor (PPI) in less than 2 weeks has never been established. Experts have suggested using pathology rather than rapid urease test (RUT). Unfortunately, pathology is not widely available in limited resource areas. We aimed to evaluate the detection rate of RUT at antrum and body compared with pathology in those patients. Methods Sixty-seven patients with history of PPI use for at least 2 weeks and continued use within 2 weeks prior to gastroscopy were enrolled. Two biopsies were taken from ..read more
Visit website
Risk stratification of hepatocellular carcinoma in patients with chronic liver disease by combining gadolinium‐ethoxybenzyl diethylenetriamine‐pentaacetic acid–enhanced magnetic resonance imaging and magnetic resonance elastography
GastroHep
by Emi Meren, Yoshiyuki Sawai, Kazuto Fukuda, Takumi Igura, Sachiyo Kogiata, Yoshihiro Yukimura, Yasushi Seki, Norihiko Fujita, Masahide Oshita, Yasuharu Imai
1y ago
Abstract Background Liver stiffness (LS) as measured by magnetic resonance elastography (MRE) and the presence of intrahepatic non-hypervascular hypointense nodules (NHHNs) during the hepatobiliary phase of gadolinium-ethoxybenzyl diethylenetriamine-pentaacetic acid–enhanced magnetic resonance imaging are non-invasive MR-based biomarkers of hepatocarcinogenesis. Methods We retrospectively evaluated the ability of these two MR-based biomarkers to stratify the risk of hepatocellular carcinoma (HCC) development in patients with chronic liver disease. Between September 2013 and April 2020, 868 con ..read more
Visit website
Helicobacter pylori Eradication by Low‐Dose Rifabutin Triple Therapy (RHB‐105) is Unaffected by High Body Mass Index
GastroHep
by John Y. Kao, June S. Almenoff, Dana Portenier, Kely L. Sheldon
1y ago
SUMMARY Background Helicobacter pylori infection affects ~35% of Americans and may lead to serious sequelae if left untreated, including gastric cancer. Obesity is a significant risk factor for antibiotic treatment failure; however, little work has been done to understand the influence of high body mass index (BMI) on the success rates of H. pylori eradication regimens in treatment-naïve and refractory adult patients. Aim This analysis evaluated the association of subject obesity on overall H. pylori eradication rates for RHB-105 (rifabutin, amoxicillin, and omeprazole magnesium; Talicia®) and ..read more
Visit website
An updated incidence of paediatric achalasia and number of myotomies performed in the United Kingdom
GastroHep
by Kitt Dokal, Mohamed Mutalib
1y ago
Abstract Background Achalasia is a rare condition characterised by an absent oesophageal peristalsis and non-relaxing lower oesophageal sphincter. The incidence of paediatric achalasia is poorly studied and inconsistently reported. We aimed to provide an up to date incidence of paediatric achalasia in the UK Methods All United Kingdom hospitals with paediatric gastroenterology and/or paediatric surgery were contacted to provide data on achalasia diagnosis and myotomies performed (2008 – 2020). Hospital Episode Statistics (HES) includes diagnostic and procedural data for all hospitals in Englan ..read more
Visit website
Post‐cholecystectomy diarrhoea: New light on old problem
GastroHep
by Her Hsin Tsai
1y ago
GastroHep, Volume 3, Issue 5, Page 276-276, September 2021 ..read more
Visit website

Follow GastroHep on Feedspot

Continue with Google
OR